MEDITE CANCER DIAGNOSTICS INC Inactive Instrument
Company Medite Cancer Diagnostics Inc OTC Bulletin Board
Equities
US58503D2009
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Jeffrey Rencher
SAM | Sales & Marketing | 56 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joel Kanter
BRD | Director/Board Member | 67 | - |
William Lewis
CHM | Chairman | 48 | 16-02-11 |
John H. Abeles
BRD | Director/Board Member | 78 | 99-04-30 |
Greg Fortunoff
BRD | Director/Board Member | 54 | 18-01-01 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 0 | 19,022 | 0 | 0 | 99.75 % |
| Stock B | 0 | 38,333 | 0 | 0 | |
| Stock C | 0 | 93,750 | 0 | 0 | |
| Stock D | 1 | 86,742,909 | 86,723,700 ( 99.98 %) | 19,209 ( 0.0221 %) | |
| Stock E | 0 | 47,250 | 0 | 0 |
Company contact information
MEDITE Cancer Diagnostics, Inc.
10524 Moss Park Road Suite 204-357
32832, Orlando
+
http://www.medite-group.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +7.62% | 219B | |
| +6.70% | 183B | |
| +11.94% | 132B | |
| +24.60% | 106B | |
| -2.66% | 62.09B | |
| +4.81% | 50.88B | |
| +11.55% | 50.8B | |
| -1.09% | 40.64B | |
| +26.82% | 31.59B |
- Stock Market
- Equities
- Stock
- Stock
- Company Medite Cancer Diagnostics Inc
